Glassman Wealth Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,762
| Closed | -$119K | – | 359 |
|
|
2023
Q4 | $119K | Buy |
1,762
+127
| +8% | +$8.55K | 0.02% | 266 |
|
|
2023
Q3 | $111K | Buy |
1,635
+346
| +27% | +$23.4K | 0.02% | 257 |
|
|
2023
Q2 | $92.3K | Sell |
1,289
-2
| -0.2% | -$143 | 0.01% | 276 |
|
|
2023
Q1 | $89.6K | Buy |
1,291
+65
| +5% | +$4.51K | 0.02% | 278 |
|
|
2022
Q4 | $83.1K | Buy |
1,226
+23
| +2% | +$1.56K | 0.02% | 302 |
|
|
2022
Q3 | $66K | Buy |
1,203
+45
| +4% | +$2.47K | 0.01% | 324 |
|
|
2022
Q2 | $77K | Sell |
1,158
-201
| -15% | -$13.4K | 0.02% | 303 |
|
|
2022
Q1 | $90K | Buy |
1,359
+320
| +31% | +$21.2K | 0.02% | 280 |
|
|
2021
Q4 | $61K | Buy |
1,039
+77
| +8% | +$4.52K | 0.01% | 330 |
|
|
2021
Q3 | $58K | Buy |
962
+300
| +45% | +$18.1K | 0.01% | 328 |
|
|
2021
Q2 | $40K | Buy |
662
+120
| +22% | +$7.25K | 0.01% | 397 |
|
|
2021
Q1 | $27K | Sell |
542
-1,357
| -71% | -$67.6K | 0.01% | 445 |
|
|
2020
Q4 | $95K | Buy |
1,899
+548
| +41% | +$27.4K | 0.02% | 235 |
|
|
2020
Q3 | $74K | Buy |
1,351
+1,306
| +2,902% | +$71.5K | 0.02% | 242 |
|
|
2020
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 822 |
|
|
2020
Q1 | $2K | Buy |
45
+14
| +45% | +$622 | ﹤0.01% | 674 |
|
|
2019
Q4 | $2K | Buy |
+31
| New | +$2K | ﹤0.01% | 726 |
|
|
2018
Q4 | – | Sell |
-244
| Closed | -$10K | – | 779 |
|
|
2018
Q3 | $10K | Buy |
244
+55
| +29% | +$2.25K | ﹤0.01% | 386 |
|
|
2018
Q2 | $7K | Hold |
189
| – | – | ﹤0.01% | 400 |
|
|
2018
Q1 | $7K | Hold |
189
| – | – | ﹤0.01% | 383 |
|
|
2017
Q4 | $7K | Buy |
+189
| New | +$7K | ﹤0.01% | 361 |
|
|
2017
Q1 | – | Sell |
-87
| Closed | -$2K | – | 570 |
|
|
2016
Q4 | $2K | Buy |
+87
| New | +$2K | ﹤0.01% | 494 |
|